Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection

Hesham Nasser(Suez Canal University), Shinya Suzu(Kumamoto University Hospital)
The Journal of Immunology
September 1, 2022
10.4049/jimmunol.2200087
Cited by 9

Related Papers

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
|Nature|2021|680
Identification of TNFAIP2 as a unique cellular regulator of CSF-1 receptor activation
|Life Science Alliance|2025|7
M-Sec promotes the accumulation of intracellular HTLV-1 Gag puncta and the incorporation of Env into viral particles
|PLoS Pathogens|2025|3